Clinical Trial Update: Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention [NA]

View source ↗

Summary

This clinical trial update describes local delivery of paclitaxel via the TAPAS catheter to prevent restenosis after femoropopliteal intervention; the trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease
• Restenosis

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Midwest Cardiovascular Research Foundation | Conditions: Restenosis, Peripheral Arterial Disease | NA | Status: UNKNOWN